Nektar Therapeutics
NKTR
#5687
Rank
NZ$2.00 B
Marketcap
NZ$98.49
Share price
-1.37%
Change (1 day)
278.67%
Change (1 year)

Nektar Therapeutics (NKTR) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.52 Billion

According to Nektar Therapeutics 's latest financial reports the company's total assets are NZ$0.52 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Nektar Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$0.53 B-14.4%
2023-12-31NZ$0.62 B-43.76%
2022-12-31NZ$1.11 B-31.57%
2021-12-31NZ$1.63 B-23.31%
2020-12-31NZ$2.13 B-27.36%
2019-12-31NZ$2.93 B-8.41%
2018-12-31NZ$3.20 B347.38%
2017-12-31NZ$0.71 B-12.75%
2016-12-31NZ$0.82 B12.72%
2015-12-31NZ$0.72 B29.26%
2014-12-31NZ$0.56 B6.59%
2013-12-31NZ$0.52 B-12.62%
2012-12-31NZ$0.60 B-22.14%
2011-12-31NZ$0.77 B15.03%
2010-12-31NZ$0.67 B-14.74%
2009-12-31NZ$0.79 B-17.97%
2008-12-31NZ$0.96 B2.04%
2007-12-31NZ$0.94 B-13.18%
2006-12-31NZ$1.09 B-13.19%
2005-12-31NZ$1.25 B20.32%
2004-12-31NZ$1.04 B10.03%
2003-12-31NZ$0.94 B-18.14%
2002-12-31NZ$1.15 B-27.86%
2001-12-31NZ$1.60 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
NZ$156.03 B 29,812.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 69,166.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 42,888.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
NZ$0.34 B-33.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$198.12 B 37,881.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
NZ$36.46 B 6,890.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$4.03 B 673.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
NZ$333.76 B 63,884.71%๐Ÿ‡บ๐Ÿ‡ธ USA